Figure 1.
Mice with global deletion of NOX2 develop lung inflammation and a subset of CD11bhigh AMs. (A) BAL leukocyte count, flow cytometric analysis of the percentage of polymorphonuclear leukocytes (PMNs) and total PMNs in 3 mL BAL from 4- and 12-week-old WT and CybbKO male and female mice (n ≥ 7 in each group). (B) Flow cytometric analysis of total AMs (CD45+Siglec F+CD11c+ cells) and total eosinophils (EOS) (CD45+Siglec F+CD11c− cells) from 3 mL of BAL (n ≥ 7). (C) ELISA of IL-1β and CXCL2 in BAL (n ≥ 3 in each group). (D) Gating strategy to identify CD11b+ AMs in the BAL (CD45+SIglec F+ CD11c+CD11bhigh). (E) Percentage of AMs that are CD11bhigh in BAL samples from different groups (n ≥ 4). (F) CD11b expression by qRT-PCR in flow-sorted AMs of different groups. WTL, WT CD11blow AMs; CybbKO L, CybbKO CD11blow AMs; and CybbKO H, CybbKO CD11bhigh AMs (n = 3). (G) Lung sections from 12-week-old WT and CybbKO mice, as indicated, stained with hematoxylin-eosin showing intracellular (arrowhead) and extracellular eosinophilic crystals (arrow) in CybbKO mice. The rightmost panel shows lung tissue from a CybbKO mouse with small infiltrates adjacent to some of the crystals. Scale bars, 100 μm. Representative images from ≥5 mice of each genotype. Bar graph data are expressed as mean ± standard error of the mean. The Student t test was performed for samples distributed in 2 groups. *P < .05; **P < .01; ***P < .001. One-way analysis of variance was performed followed by Tukey’s post hoc analysis comparing multiple groups. Data represent at least 2 independent experiments. *P < .05; **P < .01; ***P < .001; ****P < .0001. ELISA, enzyme linked immunosorbent assay.